
Ambu A/S
AMBBY
Updated: 24/09/2026, 07:56:05
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. It operates through the following segments: Anaesthesia; Patient Monitoring & Diagnostics; and Visualisation. The Anaesthesia segment offers products from resuscitators, face masks, and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics segmet provides electrodes for cardiology, neurophysiology, and polysomnography. The Visualisation segment includes single-use visualisation devices, which are used in single lung ventilation procedure, or a bedside bronchoscopy procedure in the intensive care unit . The company was founded by Holger Hesse in 1937 and is headquartered in Ballerup, Denmark.
No summaries found.
- Share price
- $10.25
- Market cap
- $2.72B
- Exchange
- OTC
- Currency
- USD
- CEO
- Britt Meelby Jensen
- Employees
- 5,384
- IPO date
- 08/01/2021
- Beta
- 1.409
- Last dividend
- $0.00
- Day range
- $10.25 – $10.25
- 52-week range
- $8.55 – $16.78
- 1-day performance
- 0.00%
- 1-year performance
- 19.95%
- Current drawdown (1Y)
- -38.92%
- CIK
- N/A
- CUSIP
- 02337W109
- ISIN
- US02337W1099
- Created
- 07/12/2025, 02:02:54
- Last update
- 24/09/2026, 07:56:05
Track Ambu A/S with an AI analyst
See which prediction-market events move AMBBY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.